NDAORALCAPSULE
Approved
May 1969
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Data completeness
2/8 — Basic
Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TAO (troleandomycin) is an oral macrolide antibiotic approved in 1969 for treating bacterial infections. It is a small-molecule macrolide that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. The drug is used primarily for respiratory and soft-tissue infections in patients who may be allergic to penicillin or have resistant organisms.
LOE Approaching
This legacy product is approaching loss of exclusivity with modest competitive pressure (30%), suggesting a shrinking brand team and focus on cost management rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
ROTAO 1 - Feasibility and Safety of the TAVIPILOT Tele-operated Robot During Transcatheter Aortic Valve Replacement (TAVR/TAVI)
Started Sep 2025
10 enrolled
TAVI(Transcatheter Aortic Valve Implantation)
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Started Nov 2020
540 enrolled
Ovarian Neoplasm EpithelialFallopian Tube NeoplasmsPeritoneal Neoplasms+3 more
TAO Outpatient Trial for Anxiety and Depression
Started Jan 2018
300 enrolled
Anxiety DisordersDepression
TruFreeze™ Airway Obstruction: TAO STUDY
Started Jul 2013
0Lung Disease AirwaysLung Diseases, ObstructiveAirway; Obstruction, With Emphysema+1 more
Worked on TAO at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.